Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Jennerex Biotherapeutics (Canada)
h-index: 3
Total citations: 557
Total papers: 4
Recent papers from Jennerex Biotherapeutics (Canada)
Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
Frontiers in Oncology · 2014
Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
Molecular Therapy — Nucleic Acids · 2014
Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis
International Journal of Cancer · 2013
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
Science Translational Medicine · 2013
Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
Cancer Gene Therapy · 2009
Development of targeted oncolytic virotherapeutics through translational research
Expert Opinion on Biological Therapy · 2008
The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
Molecular Therapy · 2008
Translation of Targeted Oncolytic Virotherapeutics from the Lab into the Clinic, and Back Again: A High-Value Iterative Loop
Molecular Therapy · 2008
From ONYX-015 to Armed Vaccinia Viruses: The Education and Evolution of Oncolytic Virus Development
Current Cancer Drug Targets · 2007
The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Current Gene Therapy · 2005
Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery
Journal of Pharmaceutical Sciences · 1999